Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Equity: 2013-2025

Historic Return on Equity for Agios Pharmaceuticals (AGIO) over the last 12 years, with Sep 2025 value amounting to -0.30%.

  • Agios Pharmaceuticals' Return on Equity fell 89.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year decrease of 89.00%. This contributed to the annual value of 0.57% for FY2024, which is 94.00% up from last year.
  • Agios Pharmaceuticals' Return on Equity amounted to -0.30% in Q3 2025, which was down 166.44% from 0.46% recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Return on Equity high stood at 1.46% for Q4 2021, and its period low was -0.52% during Q2 2024.
  • Its 3-year average for Return on Equity is -0.08%, with a median of -0.34% in 2023.
  • Per our database at Business Quant, Agios Pharmaceuticals' Return on Equity soared by 186bps in 2021 and then slumped by 181bps in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Equity (Quarterly) stood at 1.46% in 2021, then tumbled by 181bps to -0.35% in 2022, then decreased by 7bps to -0.42% in 2023, then skyrocketed by 84bps to 0.42% in 2024, then crashed by 89bps to -0.30% in 2025.
  • Its Return on Equity was -0.30% in Q3 2025, compared to 0.46% in Q2 2025 and 0.44% in Q1 2025.